GE HealthCare Technologies and Carlsmed List on Nasdaq
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
What happened
GE HealthCare Technologies and Carlsmed were both listed on Nasdaq on October 7, 2026. A comparison of the two companies showed that GE HealthCare Technologies has higher gross revenue and earnings per share than Carlsmed. Carlsmed is currently trading at a lower price-to-earnings ratio than GE HealthCare Technologies.
From dailypolitical.com
Why it matters
The companies exhibit different risk profiles, with GE HealthCare Technologies having a beta of 0.73 compared to Carlsmed's beta of 2.09. While GE HealthCare Technologies has a consensus target price of $78.52, Carlsmed has a consensus target price of $19.25, suggesting a higher potential upside for Carlsmed.
From dailypolitical.com
Who's involved
- NasdaqThe American stock exchange where the companies were listed
Keep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
Related events
- HCW Biologics announced it is listed on the Nasdaq stock exchange.
- Generate Biomedicines Inc listed its shares on the Nasdaq stock exchange on August 25, 2026.
- Amesite, listed on Nasdaq, is targeting post-acute care organizations with its platform.
- BioHarvest Sciences Inc is listed on the Nasdaq stock exchange and is receiving analyst ratings and targets from MarketBeat.
- Iovance Biotherapeutics listed its stock on Nasdaq and received Fast Track designation from the FDA.